AmerisourceBergen Corporation (NYSE:ABC) Files An 8-K Regulation FD DisclosureItem 7.01Regulation FD Disclosure.
Effective September 30, 2017, AmerisourceBergen Corporation (the "Company") combined the legacy AmerisourceBergen Drug Corporation and AmerisourceBergen Specialty Group operating segments into a single operating segment, Pharmaceutical Distribution Services. In addition, in connection with the completion of this reorganization, the Company's non-title third party logistics business, which was included within the Pharmaceutical Distribution Services reportable segment, was combined with the World Courier operating segment in Other, while the AmerisourceBergen Consulting Services distribution business (previously included in Other) is now included in the Pharmaceutical Distribution Services reportable segment. The Company revised its previously-reported segment disclosures to reflect the aforementioned changes to its reporting structure. These changes did not have a material impact to its historical reportable segment operating results.
In the attached Exhibit99.1, which is incorporated herein by reference, the Company is voluntarily furnishing a supplemental disclosure of unaudited revised reportable segment information prepared on the same basis that the Company reported the fiscal quarter ended September 30, 2017 for (a) the first, second and third fiscal quarters of fiscal 2017, and each fiscal quarter of fiscal 2016 and (b) the fiscal year ended September 30, 2016 to assist investors in analyzing the changes to its reporting structure.
The information contained in this Current Report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01Financial Statements and Exhibits.
(d)Exhibits.
The following exhibit is being furnished as part of this report:
AMERISOURCEBERGEN CORP ExhibitEX-99.1 2 exhibit991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1AMERISOURCEBERGEN CORPORATIONSUMMARY SEGMENT INFORMATION(in thousands)(unaudited)The following illustrates revised reportable segment revenue information for the periods indicated: Fiscal Year Ended September 30,…To view the full exhibit click here
About AmerisourceBergen Corporation (NYSE:ABC)
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment’s operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.
